KOKate O'COnnell

Kate O'COnnell

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kate O'COnnell has a total of 43 co-authors. Here are the top co-authors by number of shared publications:

  • Josephine Hegarty

    Catherine McAuley School of Nursing and Midwifery University College Cork Cork Ireland

    3 shared publications
  • Samantha J. Cushen

    Clinical Nutrition and Oncology Research Group, School of Food and Nutritional Sciences, University College Cork, T12 K8AF Cork, Ireland

    3 shared publications
  • Andrea Davis

    Department of Clinical Nutrition and Dietetics, Cork University Hospital, Cork, Ireland

    2 shared publications
  • Aoife Lowery

    HRB Clinical Research Facility, University of Galway, Galway, Ireland

    2 shared publications
  • Brendan Palmer

    HRB Clinical Research Facility, School of Public Health, University College Cork, Cork, Ireland; School of Public Health, University College Cork, Cork, Ireland

    2 shared publications
  • Darren Dahly

    HRB Clinical Research Facility, School of Public Health, University College Cork, Cork, Ireland; School of Public Health, University College Cork, Cork, Ireland

    2 shared publications

Latest Publications

  • Open Access

    A complex survivorship intervention utilizing electronic patient-reported outcomes in breast and gynecologic Cancer: the linking you to support and advice [LYSA] trial

    by Katie E. Johnston, Kate O'COnnell, Laia Raigal-Aran, Samantha J. Cushen, Andrea Davis, Fiona Byrne, Naoimh Flynn, Seamus O'REilly, Sinead Noonan, Dearbhaile C. Collins, et al.


  • Open Access

    A Dietitian Survivorship Clinic for Early-Stage Breast and Gynaecologic Cancer Survivors: A Dietetic Protocol for the Linking You to Support and Advice (LYSA) Randomised Controlled Trial

    by Katie E. Johnston, Kate O'COnnell, Veronica McSharry, Andrea Davis, Katie Bermingham, Fiona Byrne, Laia Raigal-Aran, Naoimh Flynn, Darren Dahly, Brendan Palmer, et al.

    Background To align with the EU Beating Cancer Plan, feasible and innovative solutions that monitor specific needs of cancer survivors, improve quality of life and long-term disease-free survival need to be investigated. The Linking You to Support and Advice (LYSA) Trial was a multisite, randomized feasibility trial, co-designed with public and patient involvement. Eligible participants had early-stage hormone receptor (HR)-positive breast or gynaecologic cancer, completed primary curative treatment within 12 months and had internet access (NCT05035173). The 12-month intervention involved a dietitian and nurse-led clinic targeting symptom management. Detailed protocols targeted towards dietetic services and interventions are limited in this cohort. The dietetic component of the LYSA Trial aims to evaluate the impact of using electronic patient reported outcomes (ePROs) on diet quality and body composition in HR-positive breast and gynaecologic cancer survivors. Over 12 months, changes in dietary intake, nutritional risk, body weight, lean tissue mass, adipose tissue mass and muscle strength will be assessed. Methods Comprehensive anthropometric and nutritional assessments were conducted at baseline and 12 months for both study arms. These included body composition through bioelectrical impedance analysis and World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) diet quality score. Participants in the experimental arm completed ePROs every 2 months for one year, assessing malnutrition risk, physical activity and weight gain concerns. A trigger-initiated nutritional management pathway, delivered via a telehealth platform was developed for worsening or severe individualised symptoms. Conclusion This protocol outlines the implementation of a dietetic cancer survivorship clinic, within a randomised control trial. The use of ePROs and digital technologies offers viable and innovative solutions to monitor the nutrition-specific needs of cancer survivors. Findings will inform the development of future dietetic survivorship services. Trial registration ClinicalTrials.gov , NCT05035173 . Retrospectively registered on September 5, 2021. Registered on OSF: doi:10.17605/OSF.IO/JM7FX.


  • Open Access

    The Women’s Health Initiative cancer survivorship clinic incorporating electronic patient-reported outcomes: a study protocol for the Linking You to Support and Advice (LYSA) randomized controlled trial

    by Noreen Kearns, Laia Raigal-Aran, Kate O’cOnnell, Andrea Davis, Katie Bermingham, Seamus O’rEilly, Dearbhaile C. Collins, Mark Corrigan, John Coulter, Vicki Cleary, et al.

    Background: The improved survival rate for many cancers in high-income countries demands a coordinated multidisciplinary approach to survivorship care and service provision to ensure optimal patient outcomes and quality of life. This study assesses the feasibility of introducing a Women’s Health Initiative cancer survivorship clinic in Ireland. Methods: The trial comprises an intervention and control arm. Two hundred participants will be recruited. Key eligibility (1) women with early-stage hormone receptor-positive breast or gynecologic cancer (cervix or endometrial), within 12 months of completion of primary curative therapy, and (2) access to the Internet. The complex intervention comprises a nurse-led clinic targeting symptom management through a trigger alert system, utilizing electronic patient-reported outcome (ePRO) assessments at baseline, and 2, 4, 6, 8, 10, and 12 months. It also includes input from a dietitian monitoring diet and nutritional status. The control group will receive their usual care pathway standard of care and attend the cancer survivorship clinic and complete ePRO assessments at the start and end of the study. The primary endpoint (feasibility) includes the proportion of enrolled participants who complete baseline and follow-up ePRO surveys and partake in health professional consultations after ePRO data triggers. Secondary endpoints include changes in cancer-related symptom scores assessed by ePROs, health-related Quality of Life Questionnaire (QLQ) scores, Appraisal Self-Care Agency-R scores, and adjuvant endocrine therapy medication adherence. A process evaluation will capture the experiences of participation in the study, and the healthcare costs will be examined as part of the economic analysis. Ethical approval was granted in December 2020, with accrual commencing in March 2021. Discussion: This protocol describes the implementation of a parallel arm randomized controlled trial (RCT) which examines the feasibility of delivering a Cancer Survivorship Clinic. The ePRO is an innovative symptom monitoring system which detects the treatment-related effects and provides individualized support for cancer survivors. The findings will provide direction for the implementation of future survivorship care. Trial registration: ClinicalTrials.gov, NCT05035173. Retrospectively registered on September 5, 2021


  • Open Access

    Understanding the financial burden of incomplete abortion: An analysis of the out-of-pocket expenditure on postabortion care in eight public-sector health care facilities in Dakar, Senegal

    by Colin Baynes, Mohamed Diadhiou, Grace Lusiola, Kate O’cOnnell, Thierno Dieng

    Timely access to treatment is essential for women when they experience abortion complications. Out-of-pocket (OOP) expenditure is a known barrier to health care access. In 2018, we assessed the financial burden of accessing postabortion care (PAC) borne by women in Dakar, Senegal, where studies estimate that half of poor women with complications obtain PAC. We interviewed 729 women following discharge from PAC. Women reported expenditures on transportation, admission, treatment, family planning, hospitalisation, complementary tests, prescriptions, other medicines and materials. We compare women’s OOP on PAC by expenditure category, type of treatment and facility type, and use multiple generalised linear regression analysis to explain variation in overall OOP and forecast it under alternate scenarios. The average OOP was USD $93.84. At health centres it was $65.47 and at hospitals it was $120.47. The average cost of PAC using dilation and curettage was $112.37, manual vacuum aspiration was $99.84, and misoprostol $61.80. Overall OOP on PAC amounts, on average, to 15% of the average monthly salary for women living in Dakar. Strategies that emphasise timely access to misoprostol for treating complications in primary care settings will address the contribution of OOP costs to Senegal’s appreciable unmet need for PAC among the poor.